Chris Wolski

Los Angeles

Chief Editor at Clinical Lab Products

Featured in: Favicon

clpmag.com Favicon

truckinginfo.com Favicon

automotive-fleet.com Favicon

schoolbusfleet.com Favicon

foodengineeringmag.com Favicon

government-fleet.com Favicon

lctmag.com Favicon

worktruckonline.com Favicon

businessfleet.com Favicon

greenfleetmagazine.com + 2 more

Articles

Vizgen and Hamamatsu Partner to Streamline Spatial Biology Workflows

5 days ago | clpmag.com | Chris Wolski

Summary:Vizgen and Hamamatsu Photonics have partnered to integrate advanced multiplex imaging and assay technologies, streamlining biomarker detection workflows for translational and clinical research applications. • Integrated Workflow: The collaboration combines Vizgen’s InSituPlex assays with Hamamatsu’s MoxiePlex imaging to deliver a seamless, scalable multiplex immunofluorescence solution.
ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening

6 days ago | clpmag.com | Chris Wolski

Summary:New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening, now available direct-to-consumer in most U.S. states for adults 50+ at average risk. • It removes common screening barriers by eliminating bowel prep, anesthesia, and time off work. New Day Diagnostics today announced the launch of ColoHealth, a blood test for colorectal cancer screening is now accessible to adults aged 50+ who are at average risk.
May/June 2025 Tech Guide: Clinical Chemistry

6 days ago | clpmag.com | Chris Wolski

Summary:The May/June 2025 issue of Clinical Lab Products features a comprehensive Tech Guide highlighting innovative products from 11 top lab providers, alongside additional product spotlights and in-depth editorial content. • The Tech Guide enables easy side-by-side comparisons of products from leading lab technology companies. • Listings and product spotlights are provided at no charge and include direct contact information for follow-up.
Partnership Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution

1 week ago | clpmag.com | Chris Wolski

Summary:AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform, enhancing diagnostic capabilities for bladder cancer in the urology market. • Partnership Expansion: Lumea is incorporating AIxMed’s AIxURO to expand its digital pathology AI offerings specifically for urine cytology.
Bioluminescence Used to Detect Viruses

1 week ago | clpmag.com | Chris Wolski

Summary:Researchers at Mass General Brigham have developed LUCAS, a powerful new bioluminescence-based diagnostic tool that offers rapid, portable, and ultra-sensitive virus detection in complex biological samples. • High Accuracy & Speed: It delivers results in under 23 minutes with over 94% accuracy across multiple viruses, including HIV and SARS-CoV-2.
Labcorp Expands Oncology Portfolio

1 week ago | clpmag.com | Chris Wolski

Summary:Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers, along with enhanced biopharma solutions to support clinical trials and diagnostic development. • New diagnostics aim to improve access and identify patients for targeted cancer therapies. • Labcorp emphasizes its role as a trusted partner across all stages of cancer care.
AMP Releases Series Defining Core Bioinformatics Competencies

1 week ago | clpmag.com | Chris Wolski

Summary:The Association for Molecular Pathology has released a three-part open-access series defining the essential roles and competencies of clinical bioinformaticians in molecular diagnostic labs. • The series outlines key domains and responsibilities critical to bioinformatics practice in clinical settings. • It was developed through expert consensus and grounded in scientific evidence and current clinical standards.
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests

1 week ago | clpmag.com | Chris Wolski

Summary:NeoGenomics launched its PanTracer Family of genomic profiling tests and Paletrra, an AI-driven spatial proteomics platform, at the 2025 ASCO Annual Meeting to enhance precision oncology and support faster, data-driven cancer treatment decisions. • PanTracer Family offers comprehensive genomic insights for advanced solid tumors, including options for tissue and liquid biopsy samples.
MRD Detection Gets New Standard with Pathlight

1 week ago | clpmag.com | Chris Wolski

Summary:SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of molecular residual disease (MRD), debuting at ASCO 2025 with clinical validation in early breast cancer. • First-of-its-kind MRD platform: Pathlight uses structural variants (SVs) as personalized tumor biomarkers, enabling precise and early detection of recurrence.
Proteograph Workflow Redefines Deep Unbiased Proteomics

1 week ago | clpmag.com | Chris Wolski

Summary:Seer, Inc. has launched its advanced Proteograph Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument, enabling scalable, affordable, and deep mass-spec based proteomic analysis for population-scale studies. • Scalability Breakthrough: The new Proteograph workflow processes over 1,000 samples per week on a single instrument, vastly improving throughput.